Baidu
map

ACC 2014:JNC8高血压指南推荐的降压治疗更为宽松

2014-03-31 高晓方 译 医学论坛网

2014年美国心脏病学会年会(ACC 2014)公布的一项研究表明,与美国预防、检测、评估和治疗高血压委员会(JNC)第7次的报告相比,JNC 8专家组成员的《2014成人高血压管理指南》(以下简称JBC 8指南)与推荐行降压治疗的成人比率降低以及实现目标血压的成人比率升高具有相关性,并且在老年成人中更为显著。论文于3月29日在线发表于《美国医学会杂志》(JAMA)。 【原文下载】 此

2014年美国心脏病学会年会(ACC 2014)公布的一项研究表明,与美国预防、检测、评估和治疗高血压委员会(JNC)第7次的报告相比,JNC 8专家组成员的《2014成人高血压管理指南》(以下简称JBC 8指南)与推荐行降压治疗的成人比率降低以及实现目标血压的成人比率升高具有相关性,并且在老年成人中更为显著。论文于3月29日在线发表于《美国医学会杂志》(JAMA)。 【原文下载】


此项全美代表性横断面研究的数据来自于全美健康和营养调查研究(NHANES),并利用JBC 8指南和JNC 7指南在16372例成人受试者中分别评估了符合指南血压目标的人数。对比两组指南所得出的符合指南推荐血压目标的受试者百分比。


结果显示,应用JNC 7指南时,进行了高血压适宜治疗的年轻成人(18~59岁)比率为20.3%;应用JBC 8指南时此比率则降至19.2%。应用JNC 7指南和JBC 8指南时,进行高血压适宜治疗的老年人(≥60岁)比率分别为68.9%和61.2%。实现血压目标的高血压成人比率呈轻度升高,由JNC 7时的41.2%升至JBC 8指南的47.5%;在老年人中上述比率升高幅度更为明显(40.0%升至65.8%)。总体而言,1.6%的年轻成人和27.6%的老年人接受降压治疗并且符合更为严格的JNC 7指南推荐的目标。应用JBC 8指南时,上述患者可能适用于较为宽松的降压治疗或无需降压治疗。

原始出处:

Ann Marie Navar-Boggan, Michael J. Pencina, Ken Williams,Allan D. Sniderman, Eric D. Peterson.Proportion of US Adults Potentially Affected by the 2014 Hypertension Guideline.JAMA. Published online March 29, 2014. doi:10.1001/jama.2014.2531【原文下载】


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1972901, encodeId=e3b619e290123, content=<a href='/topic/show?id=fec81032049' target=_blank style='color:#2F92EE;'>#JNC8#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10320, encryptionId=fec81032049, topicName=JNC8)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqPdWFricgmt6Dde2ptNxJzD6Y9c4cxpXdTo4pNlVPARAnFdKu6nWIPele9icxApTaFgibq0uVlgRiceQ/132, createdBy=4b8c2500026, createdName=ms8435843352634314, createdTime=Mon Jan 12 12:57:00 CST 2015, time=2015-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1291815, encodeId=f10c1291815b1, content=<a href='/topic/show?id=9d32981418b' target=_blank style='color:#2F92EE;'>#降压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98141, encryptionId=9d32981418b, topicName=降压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Wed Apr 02 02:57:00 CST 2014, time=2014-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1324898, encodeId=93f31324898bc, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Wed Apr 02 02:57:00 CST 2014, time=2014-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1360839, encodeId=aa2e136083952, content=<a href='/topic/show?id=87fe98146d7' target=_blank style='color:#2F92EE;'>#降压治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98146, encryptionId=87fe98146d7, topicName=降压治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Wed Apr 02 02:57:00 CST 2014, time=2014-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604111, encodeId=011b160411153, content=<a href='/topic/show?id=c2651026824e' target=_blank style='color:#2F92EE;'>#高血压指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102682, encryptionId=c2651026824e, topicName=高血压指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Wed Apr 02 02:57:00 CST 2014, time=2014-04-02, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1972901, encodeId=e3b619e290123, content=<a href='/topic/show?id=fec81032049' target=_blank style='color:#2F92EE;'>#JNC8#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10320, encryptionId=fec81032049, topicName=JNC8)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqPdWFricgmt6Dde2ptNxJzD6Y9c4cxpXdTo4pNlVPARAnFdKu6nWIPele9icxApTaFgibq0uVlgRiceQ/132, createdBy=4b8c2500026, createdName=ms8435843352634314, createdTime=Mon Jan 12 12:57:00 CST 2015, time=2015-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1291815, encodeId=f10c1291815b1, content=<a href='/topic/show?id=9d32981418b' target=_blank style='color:#2F92EE;'>#降压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98141, encryptionId=9d32981418b, topicName=降压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Wed Apr 02 02:57:00 CST 2014, time=2014-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1324898, encodeId=93f31324898bc, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Wed Apr 02 02:57:00 CST 2014, time=2014-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1360839, encodeId=aa2e136083952, content=<a href='/topic/show?id=87fe98146d7' target=_blank style='color:#2F92EE;'>#降压治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98146, encryptionId=87fe98146d7, topicName=降压治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Wed Apr 02 02:57:00 CST 2014, time=2014-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604111, encodeId=011b160411153, content=<a href='/topic/show?id=c2651026824e' target=_blank style='color:#2F92EE;'>#高血压指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102682, encryptionId=c2651026824e, topicName=高血压指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Wed Apr 02 02:57:00 CST 2014, time=2014-04-02, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1972901, encodeId=e3b619e290123, content=<a href='/topic/show?id=fec81032049' target=_blank style='color:#2F92EE;'>#JNC8#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10320, encryptionId=fec81032049, topicName=JNC8)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqPdWFricgmt6Dde2ptNxJzD6Y9c4cxpXdTo4pNlVPARAnFdKu6nWIPele9icxApTaFgibq0uVlgRiceQ/132, createdBy=4b8c2500026, createdName=ms8435843352634314, createdTime=Mon Jan 12 12:57:00 CST 2015, time=2015-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1291815, encodeId=f10c1291815b1, content=<a href='/topic/show?id=9d32981418b' target=_blank style='color:#2F92EE;'>#降压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98141, encryptionId=9d32981418b, topicName=降压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Wed Apr 02 02:57:00 CST 2014, time=2014-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1324898, encodeId=93f31324898bc, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Wed Apr 02 02:57:00 CST 2014, time=2014-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1360839, encodeId=aa2e136083952, content=<a href='/topic/show?id=87fe98146d7' target=_blank style='color:#2F92EE;'>#降压治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98146, encryptionId=87fe98146d7, topicName=降压治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Wed Apr 02 02:57:00 CST 2014, time=2014-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604111, encodeId=011b160411153, content=<a href='/topic/show?id=c2651026824e' target=_blank style='color:#2F92EE;'>#高血压指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102682, encryptionId=c2651026824e, topicName=高血压指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Wed Apr 02 02:57:00 CST 2014, time=2014-04-02, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1972901, encodeId=e3b619e290123, content=<a href='/topic/show?id=fec81032049' target=_blank style='color:#2F92EE;'>#JNC8#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10320, encryptionId=fec81032049, topicName=JNC8)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqPdWFricgmt6Dde2ptNxJzD6Y9c4cxpXdTo4pNlVPARAnFdKu6nWIPele9icxApTaFgibq0uVlgRiceQ/132, createdBy=4b8c2500026, createdName=ms8435843352634314, createdTime=Mon Jan 12 12:57:00 CST 2015, time=2015-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1291815, encodeId=f10c1291815b1, content=<a href='/topic/show?id=9d32981418b' target=_blank style='color:#2F92EE;'>#降压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98141, encryptionId=9d32981418b, topicName=降压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Wed Apr 02 02:57:00 CST 2014, time=2014-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1324898, encodeId=93f31324898bc, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Wed Apr 02 02:57:00 CST 2014, time=2014-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1360839, encodeId=aa2e136083952, content=<a href='/topic/show?id=87fe98146d7' target=_blank style='color:#2F92EE;'>#降压治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98146, encryptionId=87fe98146d7, topicName=降压治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Wed Apr 02 02:57:00 CST 2014, time=2014-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604111, encodeId=011b160411153, content=<a href='/topic/show?id=c2651026824e' target=_blank style='color:#2F92EE;'>#高血压指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102682, encryptionId=c2651026824e, topicName=高血压指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Wed Apr 02 02:57:00 CST 2014, time=2014-04-02, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1972901, encodeId=e3b619e290123, content=<a href='/topic/show?id=fec81032049' target=_blank style='color:#2F92EE;'>#JNC8#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10320, encryptionId=fec81032049, topicName=JNC8)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqPdWFricgmt6Dde2ptNxJzD6Y9c4cxpXdTo4pNlVPARAnFdKu6nWIPele9icxApTaFgibq0uVlgRiceQ/132, createdBy=4b8c2500026, createdName=ms8435843352634314, createdTime=Mon Jan 12 12:57:00 CST 2015, time=2015-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1291815, encodeId=f10c1291815b1, content=<a href='/topic/show?id=9d32981418b' target=_blank style='color:#2F92EE;'>#降压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98141, encryptionId=9d32981418b, topicName=降压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Wed Apr 02 02:57:00 CST 2014, time=2014-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1324898, encodeId=93f31324898bc, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Wed Apr 02 02:57:00 CST 2014, time=2014-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1360839, encodeId=aa2e136083952, content=<a href='/topic/show?id=87fe98146d7' target=_blank style='color:#2F92EE;'>#降压治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98146, encryptionId=87fe98146d7, topicName=降压治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Wed Apr 02 02:57:00 CST 2014, time=2014-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604111, encodeId=011b160411153, content=<a href='/topic/show?id=c2651026824e' target=_blank style='color:#2F92EE;'>#高血压指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102682, encryptionId=c2651026824e, topicName=高血压指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Wed Apr 02 02:57:00 CST 2014, time=2014-04-02, status=1, ipAttribution=)]

相关资讯

黄峻:JNC8不能否认β受体阻滞剂的“中国特色”

经过十年的等待,2014年美国成人高血压指南(JNC8)终于发布。新指南仅建议将噻嗪类利尿剂、血管紧张素转换酶抑制剂(ACEI)、血管紧张素受体阻滞剂(ARB)以及钙通道阻滞剂(CCB)作为一线降压药物,不再推荐β受体阻滞剂(BB)用于高血压患者的初始治疗。此外,在降压目标值、启动时机以及降压方案的调整策略等方面都有改变。然而,该指南一经发布便在业界引起普遍争议,有观点认为,指南没有得到美国心脏病

看(JNC8)降压目标变动的来龙与去脉

为何变动 杜克临床研究所彼得森(Peterson)教授在述评中结合美国新指南的推荐意见指出,其与JNC 7的主要区别集中于:与较年轻人群相比,老年人群的降压目标是否应更趋保守?美国新指南将60岁或以上人群的降压目标提高到<150 mmHg,同时取消了对糖尿病和肾病人群更严格血压控制的建议。 这一推荐的由来部分取决于如何理解现有的临床试验证据(或如何理解“缺乏试验证据”)。既往指南

王文教授:审慎看待美国指南,不必盲从(高血压指南)

首先介绍一下2010年修订的中国高血压指南。这是一部具有中国特点和中国证据的指南,适合中国高血压患者的预防、治疗和管理。中国高血压人群的特点与西方国家不同:① 中国人群多为高盐饮食者;② 中国是脑卒中高发区,高血压患者发生脑卒中与心肌梗死(MI)人数的比例为5:1,即脑卒中发生高于MI数倍,而西方MI发生人数等于或多于脑卒中。指南明确指出,中国治疗高血压的主要目标是预防脑卒中,而降低血压水平是脑卒

施仲伟:美JNC8与我国高血压用药差异

2013年12月18日,美国预防、检测、评估和治疗高血压委员会(JNC)8专家组成员于《美国医学会杂志》(JAMA)上在线发表了《2014成人高血压管理指南》,对于高血压用药的内容,JNC8的具体推荐包括:①非黑人患者(包括糖尿病患者)可从噻嗪类利尿剂、钙拮抗剂、血管紧张素转换酶抑制剂(ACEI)或血管紧张素受体拮抗剂(ARB)中选择一种药物开始治疗;②黑人患者(包括糖尿病患者)选择一种噻嗪类

ASH/ISH与JNC8高血压指南存在关键性差异

据Heartwire 12月19日报道,就在美国《2014成人高血压管理指南》(JNC 8)发布前一天,美国高血压学会/国际高血压学会(ASH/ISH)公布了以社区高血压管理为重点的临床实践指南。尽管两项指南存在共鸣,但亦具有数项关键性差异。 ASH/ISH指南概括了高血压流行病学、病因、评估、诊断、定义和分类等,并特设了黑人患者具体问题的专门章节。对于高血压的诊断以

孙宁玲:如何看待“JNC 8”对β受体阻滞剂的不同意见?

        2013年高血压学界好不热闹,6月15日,欧洲高血压学会与欧洲心脏病学会(ESH/ESC)联合发布了《2013版动脉高血压诊疗指南》,12月18日,第8届美国预防、检测、评估和治疗高血压委员会(JNC 8)专家组成员报告《2014成人高血压管理指南》发布,随后美国高血压学会(ASH)和国际高血压

Baidu
map
Baidu
map
Baidu
map